HEMOCHRON CITRATE APTT

HEMOCHRON CITRATE APTT is an FDA 510(k)-cleared medical device (K972831) manufactured by International Technidyne Corp.. This device is classified under the Hematology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on November 19, 1997. Regulation: 8.